PARP抑制剂
结构-活动关系
体外
小分子
对接(动物)
生物化学
铅化合物
细胞毒性
药效团
作者
Hailong Zhao,Ming Ji,Guonan Cui,Jie Zhou,Fangfang Lai,Xiaoguang Chen,Bailing Xu
标识
DOI:10.1016/j.bmc.2017.05.052
摘要
The PARP-2 selective inhibitor is important for clarifying specific roles of PARP-2 in the pathophysiological process and developing desired drugs with reduced off-target side effects. In this work, a series of novel quinazoline-2,4(1H,3H)-dione derivatives was designed and synthesized to explore isoform selective PARP inhibitors. As a result, compound 11a (PARP-1 IC50=467nM, PARP-2 IC50=11.5nM, selectivity PARP-1/PARP-2=40.6) was disclosed as the most selective PARP-2 inhibitor with high potency to date. The binding features of compound 11a within PARP-1 and PARP-2 were investigated respectively to provide useful insights for the further construction of new isoform selective inhibitors of PARP-1 and PARP-2 by using CDOCKER program.
科研通智能强力驱动
Strongly Powered by AbleSci AI